tiprankstipranks
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX

BioCryst (BCRX) Financial Statements

2,049 Followers

BioCryst Financial Overview

BioCryst's market cap is currently ―. The company's EPS TTM is $-1.067; its P/E ratio is -6.69; BioCryst is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 92.76M$ 93.40M$ 86.74M$ 82.49M-
Gross Profit$ 91.37M$ 91.76M$ 85.64M$ 81.65M$ -938.00K
EBIT$ -10.51M$ -38.58M$ -8.47M$ -45.67M$ -25.27M
EBITDA$ -10.20M$ -38.16M$ 11.70M$ -24.38M$ -6.03M
Net Income Common Stockholders$ -35.38M$ -61.73M$ -40.26M$ -75.33M$ -53.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 336.55M$ 388.99M$ 397.59M$ 412.24M$ 399.62M
Total Assets$ 467.89M$ 516.96M$ 522.92M$ 529.88M$ 509.74M
Total Debt$ 322.33M$ 317.11M$ 310.24M$ 301.51M$ 240.95M
Net Debt$ -14.23M$ -71.87M$ -87.35M$ -110.73M$ -158.67M
Total Liabilities$ 944.06M$ 972.49M$ 933.91M$ 918.60M$ 838.02M
Stockholders Equity$ -476.17M$ -455.53M$ -410.99M$ -388.71M$ -328.29M
Cash Flow-
Free Cash Flow$ -53.92M$ -9.47M$ -20.88M$ -19.28M$ -47.67M
Operating Cash Flow$ -53.68M$ -8.92M$ -19.90M$ -18.81M$ -47.51M
Investing Cash Flow$ 28.76M$ -28.47M$ 23.12M$ -19.04M$ -107.11M
Financing Cash Flow$ -1.05M$ -3.17M$ 1.23M$ 29.36M$ 5.08M
Currency in USD

BioCryst Earnings and Revenue History

BioCryst Debt to Assets

BioCryst Cash Flow

BioCryst Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis